---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-015784"
form_type: "8-K"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2025-09-26T23:59:59+00:00"
generated_at: "2026-05-17T05:36:27.819715+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Tevogen Bio gets Nasdaq deficiency notice; must regain $1.00 bid by March 2026

## Summary
- Received letter on September 23, 2025 from Nasdaq Staff for non-compliance with $1.00 minimum bid price rule.
- Common stock closing bid below $1.00 for 30 consecutive business days; no immediate impact on listing.
- Has 180 days (until March 23, 2026) to regain compliance by closing at $1.00+ for at least 10 consecutive days.
- If not cured, may transfer to Nasdaq Capital Market for an additional 180-day compliance period.
- Company will monitor bid price and evaluate options; no assurance of regaining compliance.

## SEC filing metadata
- accession: 0001493152-25-015784
- form_type: 8-K
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2025-09-26T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000149315225015784/0001493152-25-015784-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000149315225015784/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-015784
- JSON: https://secwatch.observer/filing/0001493152-25-015784.json
- Plain text: https://secwatch.observer/filing/0001493152-25-015784.txt

## Key facts
- Listing & Compliance Notices
  Tevogen Bio Holdings Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1)
  source text: September 23, 2025, Tevogen Bio Holdings Inc. (the “Company”) received a letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company no longer meets Nasdaq’s $1.00 per share minimum bid price requirement pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”) for continued listing on Nasdaq based on the closing bid price for the Company’s common stock, par value $0.0001 per share (the “Common Stock”), for the previous 30 consecutive business days. The notification received has no immediate eff
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860871/000149315225015784/0001493152-25-015784-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.